View Cart (0 items)


Global spending on medicines to grow by up to 6% per year through 2017

December 11, 2013
The key factors that will drive global drug markets are better access to medicines due to rising disposable income in developing countries and more favorable economic conditions in emerging markets.
Read More

FDA imposes new ban on Wockhardt drugs

December 4, 2013
Indian generic drug maker Wockhardt has been hit by a U.S. import alert for the second time this year.
Read More

Chinese anti-trust authorities launch probe into Bayer

September 24, 2013
German pharmaceutical giant Bayer AG is being investigated by Chinese authorities for unfair competition, becoming the latest foreign drug maker to come under examination in the Asian country.
Read More

Fatburner Dexaprine banned in UK, Netherlands

August 23, 2013
Slimming agent Dexaprine, produced by California-based company iForce Nutrition, has been banned in the Netherlands and the United Kingdom over concerns that the fatburner causes a number of life-threatening conditions.
Read More

Novartis feels the heat as China opens another bribery probe

August 22, 2013
Chinese authorities are stepping up their crusade against widespread bribery in the pharmaceutical sector with a newly launched investigation.
Read More

Chinese pharma probe spreads to two Danish drug makers

August 13, 2013
Western pharmaceutical companies are coming under increased scrutiny in China following the bribery accusations leveled last month against GlaxoSmithKline (GSK).
Read More

European biotechs back on venture capital radar

August 8, 2013
Venture capital firms are once again warming to European biotechnology players, which attracted a significant portion of the venture capital invested globally in this sector during the second quarter.
Read More

FDA sends warning letter to Indian drug maker

July 29, 2013
Mumbai-based pharmaceutical firm Wockhardt Ltd has announced that it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding the import alert on production originating from the company's Waluj facility in India.
Read More

AstraZeneca to build new HQ, research center in Cambridge, UK

June 19, 2013
AstraZeneca is investing about £330 million ($515.6 million) in its new building, which will host a global R&D center.
Read More

FDA takes action against Indian pharmaceutical companies

June 3, 2013
Pharmaceutical company Hospira Inc. has been warned by the U.S. Food and Drug Administration (FDA) over lapses in the manufacturing of drugs, which were detected during an inspection of its facility in Irungattukottai, India, in October 2012.
Read More